[CUV] YoY Annual Result on 30-Jun-2024 [#FY]

Stock
[CUV] Clinuvel Pharmaceuticals Limited
Announcement Date
29-Jun-2024
Financial Year
2024
Quarter
30-Jun-2024 [#FY]
Profit Trend
YoY- 16.44%
Quarter Report
CUV's Result
CUV's Financial Summary
View:
Show?
Annual Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 88,178 78,321 65,722 47,976 32,565 31,048 25,486 22.95%
PBT 50,679 45,579 34,321 25,713 11,541 18,115 12,942 25.52%
Tax 15,043 14,974 13,442 984 -3,510 19 282 93.90%
NP 35,636 30,605 20,878 24,728 16,647 18,134 13,224 17.94%
Tax Rate -29.68% -32.85% -39.17% -3.83% 30.42% -0.11% -2.18% -
Total Cost 52,542 47,717 44,844 23,247 15,919 12,914 12,262 27.41%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 40.41 39.08 31.77 51.54 51.12 58.41 51.89 -4.07%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.70 0.62 0.42 0.50 0.31 0.38 0.28 16.48%
EPS Diluted 0.70 0.59 0.40 0.48 0.30 0.37 0.27 17.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.